Table 1. Selection of key nomenclature... | American Society of Hematology

Table 1.

Selection of key nomenclature and classification changes over time for BPDCN

Year	Classification	Nomenclature	Disease category	Reference
2001	WHO	Blastic NK-cell lymphoma	Lymphoma	Jaffe et al,⁵⁷ IARC Press 2001
2005	WHO-EORTC	Agranular CD⁴+CD⁵⁶+ hematodermic neoplasm	Cutaneous lymphomas	Willemze et al,⁵⁸Blood 2005
2008	WHO	BPDCN	AML and related neoplasms	Vardiman,²Blood 2009
2016	WHO	BPDCN	Myeloid neoplasms	Arber et al,³Blood 2016
2022	WHO 5^th edition	BPDCN	Dendritic cell and histiocytic neoplasms (subcategory: plasmacytoid dendritic cell neoplasms)	Khoury et al,¹²Leukemia 2022
2022	International Consensus Classification (ICC) of Myeloid Neoplasms and Acute Leukemias	BPDCN	Myeloid neoplasms and acute leukemias	Arber et al,⁵⁹Blood 2022

Year	Classification	Nomenclature	Disease category	Reference
2001	WHO	Blastic NK-cell lymphoma	Lymphoma	Jaffe et al,⁵⁷ IARC Press 2001
2005	WHO-EORTC	Agranular CD⁴+CD⁵⁶+ hematodermic neoplasm	Cutaneous lymphomas	Willemze et al,⁵⁸Blood 2005
2008	WHO	BPDCN	AML and related neoplasms	Vardiman,²Blood 2009
2016	WHO	BPDCN	Myeloid neoplasms	Arber et al,³Blood 2016
2022	WHO 5^th edition	BPDCN	Dendritic cell and histiocytic neoplasms (subcategory: plasmacytoid dendritic cell neoplasms)	Khoury et al,¹²Leukemia 2022
2022	International Consensus Classification (ICC) of Myeloid Neoplasms and Acute Leukemias	BPDCN	Myeloid neoplasms and acute leukemias	Arber et al,⁵⁹Blood 2022

BPDCN, blastic plasmacytoid dendritic cell neoplasm; EORTC, European Organisation for Research and Treatment of Cancer.